These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 519148)

  • 21. Cytotoxicity of hypoxic cell sensitizers in multicell spheroids.
    Sutherland RM; Bareham BJ; Reich KA
    Cancer Clin Trials; 1980; 3(1):73-83. PubMed ID: 7389039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interactions between misonidazole and hyperthermia in EMT6 spheroids.
    Morgan JE; Bleehen NM
    Br J Cancer; 1981 Dec; 44(6):810-8. PubMed ID: 7326192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In situ drug delivery.
    Levin VA; Wright DC; Landahl HD; Patlak CS; Csejtey J
    Br J Cancer Suppl; 1980 Apr; 4():74-8. PubMed ID: 6932949
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of prolonged exposure of HELA S3 cells to low concentrations of misonidazole.
    Ohizumi Y; Shibata C; Maezawa H; Ushiro S; Mori T
    Gan; 1981 Oct; 72(5):717-22. PubMed ID: 7327372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of misonidazole on the cytotoxicity and DNA cross-linking activity of an activated sulfidocyclophosphamide in hypoxic mouse leukemia cells.
    Ramonas LM; Erickson LC; McManus ME
    Mol Pharmacol; 1982 Jul; 22(1):175-81. PubMed ID: 7121448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of misonidazole as a hypoxic radiosensitizer at low dose.
    Palcic B; Faddegon B; Skarsgard LD
    Radiat Res; 1984 Nov; 100(2):340-7. PubMed ID: 6494445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanism of misonidazole-linked cytotoxicity and altered radiation response: role of cellular thiols.
    Biaglow JE; Varnes ME; Astor M; Hall EJ
    Br J Radiol; 1981 Nov; 54(647):1006-8. PubMed ID: 7306759
    [No Abstract]   [Full Text] [Related]  

  • 28. Radiosensitizing effect of misonidazole in fractionated gamma-ray treatment of a human malignant melanoma grown in athymic nude mice.
    Rofstad EK; Brustad T
    Br J Radiol; 1979 May; 52(617):393-7. PubMed ID: 444837
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The demonstration of in vivo misonidazole tumour toxicity using post radiation hypoxia.
    Gomer CJ; Johnson RJ; Hetzel FW; Lawrence G
    Br J Cancer Suppl; 1978 Jun; 3():228-31. PubMed ID: 277234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Plasma and tissues distribution of misonidazole (RO 07-0582) in the rat bearing a chimio induced tumor (author's transl)].
    Akel G; Canal P; Bugat R; Soula G; Combes PF
    J Pharmacol; 1981; 12(4):383-91. PubMed ID: 7321570
    [TBL] [Abstract][Full Text] [Related]  

  • 31. On the sensitisation of skin radionecrosis in mice by misonidazole at low doses.
    Hendry JH; Sutton ML
    Br J Radiol; 1984 Jun; 57(678):507-14. PubMed ID: 6722448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The response of EMT6 tumor spheroids to combined treatment with misonidazole and either nitrogen mustard, adriamycin, or BCNU.
    Twentyman PR
    Cancer Clin Trials; 1980; 3(3):253-6. PubMed ID: 7438322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Action of misonidazole on L5178Y-R and L5178Y-S cells. II. Cytotoxicity and radiosensitization under hypoxic conditions.
    Niepokojczycka E; Szumiel I; Walicka M
    Neoplasma; 1981; 28(4):435-40. PubMed ID: 7290267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is tumour radiosensitization by misonidazole a general phenomenon?
    Denekamp J; Hirst DG; Stewart FA; Terry NH
    Br J Cancer; 1980 Jan; 41(1):1-9. PubMed ID: 7362769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of misonidazole in situ on the radiation response of selected tumor subpopoulations.
    Grdina DJ; Sigdestad CP; Jovonovich JA
    Cancer Clin Trials; 1980; 3(2):149-54. PubMed ID: 7428138
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of oxygen and misonidazole on cell transformation and cell killing in C3H 10T1/2 cells by X rays in vitro.
    Borsa J; Sargent MD; Einspenner M; Azzam EI; Raaphorst GP
    Radiat Res; 1984 Oct; 100(1):96-103. PubMed ID: 6494435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics and cytotoxicity of RSU-1069 in subcutaneous 9L tumours under oxic and hypoxic conditions.
    Wong KH; Koch CJ; Wallen CA; Wheeler KT
    Br J Cancer; 1991 Apr; 63(4):484-8. PubMed ID: 2021530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of misonidazole on some physiologic parameters in mice.
    Conroy PJ; von Burg R; Passalacqua W; Sutherland RM
    J Pharmacol Exp Ther; 1980 Jan; 212(1):47-52. PubMed ID: 7351625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of pretreatment with phenobarbitone and phenytoin on the pharmacokinetics and toxicity of phenytoin on the pharmacokinetics and toxicity of misonidazole in mice.
    Workman P
    Br J Cancer; 1979 Sep; 40(3):335-53. PubMed ID: 508562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetic and anti-tumor studies with the radiosensitizer misonidazole in dogs with spontaneous fibrosarcomas.
    Creasey WA; Thrall DE
    Am J Vet Res; 1982 Jun; 43(6):1015-8. PubMed ID: 7103170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.